How to Assess Comorbidity and Work Function in Major Depressive Disorder
How should clinicians evaluate comorbid conditions and occupational impairment when treating adults with major depressive disorder?
Adults with major depressive disorder often present with burdens that extend beyond depressive symptoms alone. In The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010), most incremental costs in people with MDD were linked to comorbid conditions and workplace impairment, so routine MDD care should explicitly assess both domains.
-
Look beyond depressive symptoms at the initial assessment
Approach the visit with the expectation that major depressive disorder is accompanied by substantial excess burden outside MDD treatment itself. In this study, only 38% of total incremental costs in adults with MDD were attributable to MDD itself, meaning the majority was associated with comorbid conditions.
-
Screen for common psychiatric and physical comorbidities noted in the study
Ask specifically about other mental health conditions and physical symptom clusters that commonly contributed to excess direct costs in adults with MDD. The article highlights anxiety, adjustment disorder, and posttraumatic stress disorder, along with pain manifestations such as disc and back disorders, abdominal pain, chest pain, sleep disorders, and migraines.
-
Assess work functioning directly
Do not limit functional assessment to whether the patient is missing work. Ask about reduced effectiveness while at work as well as days missed, because presenteeism accounted for approximately three quarters of workplace costs and represented 37% of the overall economic burden.
-
Document employment status as part of clinical risk context
Record whether the patient is employed full-time, employed part-time, unemployed, or not looking for work. The article found that adults with MDD had lower full-time employment than those without MDD, and that this gap widened between 2005 and 2010, indicating that employment status is a meaningful part of illness burden.
-
Recognize that treatment engagement may still be incomplete
Do not assume that contact with care means the broader burden of MDD is being adequately addressed. Even though treatment rates increased from 52.2% to 56.2% between 2005 and 2010, the overall economic burden still rose substantially.
-
Coordinate care when comorbidity is prominent
When patients with major depressive disorder also have important medical or psychiatric comorbidity, consider care approaches that integrate depression treatment with broader medical management. The discussion notes that collaborative care approaches mindful of these different pathways may allow long-term cost savings.
Clinical Considerations
- This article is an economic burden analysis and does not test a clinical screening tool or treatment algorithm for comorbidities or workplace impairment.
- The findings are based on mixed sources including national survey data, administrative claims, and literature-based assumptions rather than a single clinical dataset.
- There were no severity markers in the underlying data, so the study could not determine how this workflow should vary by depression severity.
- Adults aged 65 years and older were not observed directly in the claims data, and their costs were imputed from the 50-64 year age group.
Bottom Line
When treating major depressive disorder, routinely assess comorbid psychiatric and physical conditions and on-the-job functioning, because most excess burden is driven by those domains rather than by MDD treatment costs alone.
